Five Star Senior Living Inc.

Five Star Senior Living Inc. operates and manages senior living communities in the United States. It operates through Senior Living, and Rehabilitation and Wellness segments. Its senior living communities comprise independent living communities, assisted living communities, continuing care retirement communities (CCRCs), skilled nursing facilities (SNFs), and an active adult community. The company offers nursing and healthcare services; and rehabilitation and wellness services. As of December 31, 2020, it operated 268 senior living communities consisting of 29,271 living units comprising 243 primarily independent and assisted living communities with 28,316 living units, and 9 SNFs with 955 living units located in 31 states. The company was formerly known as Five Star Quality Care, Inc. and changed its name to Five Star Senior Living Inc. in March 2017. Five Star Senior Living Inc. was founded in 2001 and is headquartered in Newton, Massachusetts.

Five Star Senior Living Inc. trades as FVE on NASDAQ. The company is classified in Healthcare / Medical - Care Facilities and reports in USD.

The current profile places the business in Medical - Care Facilities. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows $934.59M of revenue and -$29.75M of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Five Star Senior Living Inc. can be compared against peers such as Aadi Bioscience, Inc., AlerisLife Inc., Asensus Surgical, Inc., HilleVax, Inc., Jounce Therapeutics, Inc., Miromatrix Medical Inc..

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $98.39M, beta of 1.03, and return on equity of -16.4%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

FVE currently shows total debt of $20.77M and beta of 1.03. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.fivestarseniorliving.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.